06.11.2017 • NewsElaine BurridgeSKDow

SK Buys Dow’s PVDC Business

(c) SFIO CRACHO/Shutterstock
(c) SFIO CRACHO/Shutterstock

SK Global Chemical, part of SK Innovation, is buying another asset from Dow Chemical, this time its polyvinylidene chloride (PVDC) business. The acquisition includes all production facilities in the US state of Michigan, technologies and patents, as well as the Saran brand name.

PVDC is used primarily for household wrap and food/medicine film packaging because of its transparency and high barrier properties.

The purchase price was not disclosed, but sources said the acquisition could be worth $100 million. The deal is expected to close by the end of the year.

This latest transaction follows SK’s purchase of Dow’s ethylene acrylic acid (EAA) business for $370 million, which completed in September, as the South Korean company seeks to diversify and expand into the packaging and automotive markets. The group has previously stated its plans to turn SK Global Chemical into one of the world’s 10 largest chemical companies with sales of 33 trillion won by 2024.

A focus on China is also a key part of SK’s Deep Change 2.0 strategy. According to The Korea Herald newspaper, SK and Sinopec are planning to invest 740 billion won ($656 million) to expand capacity at their joint venture, Sinopec-SK Wuhan Petrochemical in Wuhan, Hubei province.

The partners expect to increase capacity at the complex from 2.2 million t/y for ethylene and derivatives (including PE and PP) to 3 million t/y by 2020.
 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read